treatment of cells with drugs that disrupt actin networks , cytochalasin d or erythro-9- [ 3- ( 2-hydroxynonyl ) ] adenosine eliminates retraction regardless of the absence of mts , lack of adhesion to the substratum , or integrity of the neurite .
C0007634
cells
C0026046
mts